Anti–IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis
Autor: | Lamothe, Pedro A., Humphrey Pruett, Charles Lewis, Smirnova, Natalia, Shepherd, Aaron, Runnstrom, Martin C., Park, Jiwon, Zhang, Rebecca H., Zhao, Leshan, Swenson, Colin, Eun-Hyung Lee, F. |
---|---|
Zdroj: | In Journal of Allergy and Clinical Immunology: Global October 2024 |
Databáze: | ScienceDirect |
Externí odkaz: |